封面
市场调查报告书
商品编码
1646181

临床决策支援系统市场规模、份额和成长分析(按组件、产品、类型、模型、交付方式、应用、互动程度、环境和地区)- 产业预测,2025-2032 年

Clinical Decision Support System Market Size, Share, Growth Analysis, By Component, By Product, By Type, By Model, By Delivery Mode, By Application, By Interactivity Level, By Setting, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 260 Pages | 商品交期: 3-5个工作天内

价格
简介目录

临床决策支援系统 (CDSS) 市场规模预计在 2023 年达到 21 亿美元,并从 2024 年的 22.6 亿美元成长到 2032 年的 40.9 亿美元,预测期内(2025-2032 年)的复合年增长率为 7.7%。

由于对整合到优质医疗保健中的可靠技术解决方案的需求不断增加,临床决策支援系统 (CDSS) 市场正在经历显着增长。这一增长得益于全球各国政府的支持倡议,例如在医疗机构实施资讯系统以及严格的 FDA 和 CE 标誌法规等,以确保产品的完整性。 COVID-19 疫情凸显了 CDSS 的重要性。 CDSS 为医疗团队提供最新的医疗知识,并在患者人数众多的情况下提高护理品质。 COvid 风险计算器 (CORAL) 等创新证明了 CDSS 与电子健康记录的成功整合。此外,对远端监控工具和高效健康资料传输的需求激增,促使市场相关人员透过 COVID-19 功能增强 EHR 功能,从而进一步推动了对联网医疗设备的需求。

目录

介绍

  • 调查目的
  • 研究范围
  • 定义

调查方法

  • 资讯采购
  • 资料和主要资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分机会分析

市场动态及展望

  • 市场概况
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特的分析

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 市场吸引力指数(2024 年)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 客户和购买标准分析
  • 监管分析

临床决策支援系统市场规模(按组件和复合年增长率)(2025-2032)

  • 市场概况
  • 服务
  • 软体
  • 硬体

临床决策支援系统市场规模(按产品和复合年增长率) (2025-2032)

  • 市场概况
  • 整合式 CDSS
  • 独立 CDSS

临床决策支援系统市场规模(按类型和复合年增长率)(2025-2032)

  • 市场概况
  • 治疗性CDSS
  • 诊断性CDSS

临床决策支援系统市场规模(按型号和复合年增长率)(2025-2032)

  • 市场概况
  • 基于知识的CDSS
  • 非基于知识的CDSS

临床决策支援系统市场规模(依交付模式和复合年增长率)(2025-2032)

  • 市场概况
  • 本地 CDSS
  • 云端基础的CDSS

临床决策支援系统市场规模(按应用和复合年增长率)(2025-2032)

  • 市场概况
  • 常规CDSS
  • 先进的CDSS

临床决策支援系统市场规模(按互动程度和复合年增长率) (2025-2032)

  • 市场概况
  • 主动式 CDSS
  • 被动式CDSS

临床决策支援系统市场规模(按环境和复合年增长率) (2025-2032)

  • 市场概况
  • 住院环境
  • 门诊治疗环境

临床决策支援系统市场规模(按地区)及复合年增长率(2025-2032)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲国家
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前 5 家公司对比
  • 主要企业市场定位(2024年)
  • 主要市场参与者所采用的策略
  • 近期市场趋势
  • 公司市场占有率分析(2024 年)
  • 主要企业简介
    • 公司简介
    • 产品系列分析
    • 按细分市场分析市场份额
    • 收益与前一年同期比较对比(2022-2024 年)

主要企业简介

  • Epic Systems Corporation(United States)
  • Oracle(United States)
  • Athenahealth(United States)
  • Elsevier(division of RELX Group)(Netherlands)
  • Koninklijke Philips NV(Netherlands)
  • Medical Information Technology, Inc.(MEDITECH)(United States)
  • CureMD Healthcare(United States)
  • EBSCO Information Services(United States)
  • GE Healthcare(United States)
  • eClinicalWorks, LLC(United States)
  • The Medical Algorithms Company Limited(United Kingdom)
  • Hera-MI(France)
  • RampMedical(Germany)
  • VisualDx(United States)
  • First Databank, Inc.(FDB)(United States)
  • Strata Decision Technology(United States)
  • Alcidion(Australia)

结论和建议

简介目录
Product Code: SQSG45F2024

Clinical Decision Support System Market size was valued at USD 2.1 billion in 2023 and is poised to grow from USD 2.26 billion in 2024 to USD 4.09 billion by 2032, growing at a CAGR of 7.7% during the forecast period (2025-2032).

The market for clinical decision support systems (CDSS) is experiencing significant growth driven by the rising demand for reliable technical solutions integrated into quality healthcare. This growth is fueled by the implementation of information systems in healthcare facilities and supportive global government initiatives, particularly with stringent FDA and CE Mark regulations ensuring product integrity. The COVID-19 pandemic has underscored the importance of CDSS, as it provides healthcare teams with the latest medical insights, enhancing care quality amidst overwhelming patient volumes. Innovations like the COvid Risk cALculator (CORAL) exemplify successful integrations of CDSS into electronic health records. Furthermore, the need for remote monitoring tools and efficient health data transmission has surged, prompting market players to enhance EHR functionalities with COVID-19 features, thus driving further demand for connected medical devices.

Top-down and bottom-up approaches were used to estimate and validate the size of the Clinical Decision Support System market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Clinical Decision Support System Market Segments Analysis

Global Clinical Decision Support System Market is segmented by Component, Product, Type, Model, Delivery Mode, Application, Interactivity Level, Setting and region. Based on Component, the market is segmented into Services,Softwareand Hardware. Based on Product, the market is segmented into Integrated CDSS and Standalone CDSS. Based on Type, the market is segmented into Therapeutic CDSS and Diagnostic CDSS. Based on Model, the market is segmented into Knowledge-Based CDSS and Non-Knowledge-Based CDSS. Based on Delivery Mode, the market is segmented into On-Premise CDSS and Cloud-Based CDSS. Based on Application, the market is segmented into Conventional CDSS and Advanced CDSS. Based on Interactivity Level, the market is segmented into Active CDSS and Passive CDSS. Based on Setting, the market is segmented into Inpatient Settings and Ambulatory Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Clinical Decision Support System Market

In 2021, health ministers within the European Union collaborated to establish an eHealth common area, facilitating the seamless exchange of electronic health records across the continent. This initiative emphasizes the integration of eHealth into the Europe 2021 strategy, aiming to enhance healthcare efficiency and interoperability. As a result, the growing emphasis on electronic health records (EHR) is anticipated to drive demand for Clinical Decision Support Systems (CDSS) in significant global markets. The implementation of such policies and initiatives will undoubtedly bolster the adoption of CDSS, ultimately improving patient care by enabling better clinical decision-making through enhanced data accessibility and sharing.

Restraints in the Clinical Decision Support System Market

The global clinical decision support systems market is anticipated to face growth obstacles stemming from healthcare providers' reluctance to implement and maintain these systems. This resistance may be attributed to factors such as high installation costs, concerns about system compatibility, and the need for extensive training for healthcare personnel. Additionally, fears regarding data privacy and the integration of new technologies into existing workflows may further hinder the adoption of clinical decision support systems. As a result, these challenges could significantly impact the overall expansion and effectiveness of such systems in enhancing clinical decision-making processes.

Market Trends of the Clinical Decision Support System Market

The Clinical Decision Support System (CDSS) market is witnessing significant growth driven by increased partnerships between CDSS providers and healthcare institutions. This trend is fueled by government initiatives promoting the integration of CDSS with Electronic Health Records (EHR), aimed at enhancing clinical efficiency and reducing time spent on patient data retrieval. As a result, there has been a notable adoption of CDSS in American hospitals, with approximately 41% having a CDSS integrated with EHR systems in 2021. The U.S. government's financial incentives further boost this trend, encouraging hospitals to implement advanced CDSS technologies. Collaborative efforts among businesses to develop up-to-date software solutions are anticipated to sustain growth in this sector.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Customer And Buying Criteria Analysis
  • Regulatory Analysis

Global Clinical Decision Support System Market Size by Component & CAGR (2025-2032)

  • Market Overview
  • Services
  • Software
  • Hardware

Global Clinical Decision Support System Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Integrated CDSS
  • Standalone CDSS

Global Clinical Decision Support System Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Therapeutic CDSS
  • Diagnostic CDSS

Global Clinical Decision Support System Market Size by Model & CAGR (2025-2032)

  • Market Overview
  • Knowledge-Based CDSS
  • Non-Knowledge-Based CDSS

Global Clinical Decision Support System Market Size by Delivery Mode & CAGR (2025-2032)

  • Market Overview
  • On-Premise CDSS
  • Cloud-Based CDSS

Global Clinical Decision Support System Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Conventional CDSS
  • Advanced CDSS

Global Clinical Decision Support System Market Size by Interactivity Level & CAGR (2025-2032)

  • Market Overview
  • Active CDSS
  • Passive CDSS

Global Clinical Decision Support System Market Size by Setting & CAGR (2025-2032)

  • Market Overview
  • Inpatient Settings
  • Ambulatory Care Settings

Global Clinical Decision Support System Market Size & CAGR (2025-2032)

  • North America (Component, Product, Type, Model, Delivery Mode, Application, Interactivity Level, Setting)
    • US
    • Canada
  • Europe (Component, Product, Type, Model, Delivery Mode, Application, Interactivity Level, Setting)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Component, Product, Type, Model, Delivery Mode, Application, Interactivity Level, Setting)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Component, Product, Type, Model, Delivery Mode, Application, Interactivity Level, Setting)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Component, Product, Type, Model, Delivery Mode, Application, Interactivity Level, Setting)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Epic Systems Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oracle (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Athenahealth (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Elsevier (division of RELX Group) (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medical Information Technology, Inc. (MEDITECH) (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CureMD Healthcare (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EBSCO Information Services (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • eClinicalWorks, LLC (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • The Medical Algorithms Company Limited (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hera-MI (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • RampMedical (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • VisualDx (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • First Databank, Inc. (FDB) (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Strata Decision Technology (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alcidion (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations